| Authors: |
Hawkins PCT; Centre for Neuroimaging Sciences, Institute of Psychiatry, Psychology & Neurosciences, King's College London, London, SE5 8AF, UK., Schwarz AJ; Takeda Pharmaceuticals Ltd, Cambridge, MA, 02139, USA., Stone JM; Centre for Neuroimaging Sciences, Institute of Psychiatry, Psychology & Neurosciences, King's College London, London, SE5 8AF, UK.; Brighton and Sussex Medical School, University of Sussex, Brighton, UK., Pepper F; Centre for Neuroimaging Sciences, Institute of Psychiatry, Psychology & Neurosciences, King's College London, London, SE5 8AF, UK., Gilleen J; Centre for Neuroimaging Sciences, Institute of Psychiatry, Psychology & Neurosciences, King's College London, London, SE5 8AF, UK., Gijsen S; Centre for Neuroimaging Sciences, Institute of Psychiatry, Psychology & Neurosciences, King's College London, London, SE5 8AF, UK., Mazibuko N; Centre for Neuroimaging Sciences, Institute of Psychiatry, Psychology & Neurosciences, King's College London, London, SE5 8AF, UK., Arkilo D; Takeda Pharmaceuticals Ltd, Cambridge, MA, 02139, USA., Yin W; Takeda Pharmaceuticals Ltd, Cambridge, MA, 02139, USA., Wu J; Takeda Pharmaceuticals Ltd, Cambridge, MA, 02139, USA., Khudyakov P; Takeda Pharmaceuticals Ltd, Cambridge, MA, 02139, USA., Behrje R; Takeda Pharmaceuticals Ltd, Cambridge, MA, 02139, USA., Rosen L; Takeda Pharmaceuticals Ltd, Cambridge, MA, 02139, USA., Posener J; Takeda Pharmaceuticals Ltd, Cambridge, MA, 02139, USA., Mehta MA; Centre for Neuroimaging Sciences, Institute of Psychiatry, Psychology & Neurosciences, King's College London, London, SE5 8AF, UK. Mitul.Mehta@kcl.ac.uk., Laurenza A; Takeda Pharmaceuticals Ltd, Cambridge, MA, 02139, USA. antonio.laurenza@takeda.com. |
